Business
Announcement on Voluntary Disclosure of New Drug Application Acceptance for the Recombinant Anti-IL-4Rα Humanized Monoclonal Antibody Injection
Announcement on Voluntary Disclosure of New Drug Application Acceptance for the Recombinant Anti-IL-4Rα Humanized Monoclonal Antibody Injection
About this update from Sunshine Guojian Pharmaceutical (shanghai) Co., Ltd. Class A
Announcement on Voluntary Disclosure of New Drug Application Acceptance for the Recombinant Anti-IL-4Rα Humanized Monoclonal Antibody Injection The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment